In a recent example from our own work, we contributed to a collaborative exploration of mitochondrial involvement downstream of cytoplasmic Nucleophosmin 1 (NPM1c) in hematological disorders; this study demonstrated that NPM1c targets PML and promotes cell growth through blunting the biogenesis of PML nuclear bodies and weakening mitochondrial fitness [61]. Here, PML is linked to hematologic disorder.